| AKT, Akt | protein kinase B |
| AMPK | adenosine monophosphate-activated protein kinase |
| ATP | adenosine 5′-triphosphate |
| cAMP-PKA | cyclic adenosine monophosphate protein kinase A |
| CLP | common lymphoid progenitor |
| CP | cyclophosphamide |
| CR | complete response |
| CT | chemotherapy |
| DC | dendritic cells |
| DSR | differential stress resistance |
| DXR | doxorubicin |
| ECM | extracellular matrix |
| EGR1 | early growth response 1 |
| FMD | fasting mimicking diet |
| G-CSF | granulocyte colony-stimulating factor |
| HER2 | human epidermal growth factor receptor 2 |
| HO-1 | heme oxygenase-1 |
| HR+ | hormone receptor positive |
| ICD | immunogenic cell death |
| IFNγ | interferon gamma |
| IGF-1 | insulin growth factor 1 |
| IGF1R | insulin growth factor 1 receptor |
| M-CSF | macrophage colony-stimulating factor |
| MDSC | myeloid derived suppressor cells |
| mTOR | mammalian target of rapamycin |
| MTX | mitoxantrone |
| NK | natural killer cell |
| OX | oxaliplatin |
| PBMC | peripheral blood mononuclear cell |
| PD1 | programmed cell death protein 1 |
| PD-L1 | programmed cell death protein 1 ligand |
| PI3K | phosphoinositide 3-kinase |
| PR | partial response |
| QoL | quality of life |
| ROS | reactive oxygen species |
| RT | radiation therapy |
| STF | short-term fasting |
| TAC | docetaxel/doxorubicin/cyclophosphamide |
| TAM | tumor associated macrophages |
| TIL | tumor infiltrating lymphocyte |
| Tregs | regulatory T cells |